Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

被引：0

作者：

Haude, Michael ^{[1
]}

Ince, Huseyin ^{[2
,3
]}

Kische, Stephan ^{[4
]}

Abizaid, Alexandre ^{[5
]}

Toelg, Ralph ^{[6
]}

Lemos, Pedro A. ^{[7
]}

Van Mieghem, Nicolas ^{[8
]}

Verheye, Stefan ^{[9
]}

von Birgelen, Clemens ^{[10
]}

Christiansen, Evald ^{[11
]}

Barbato, Emanuele ^{[12
]}

Neumann, Franz-Josef ^{[13
]}

Witzenbichler, Bernhard ^{[14
]}

Kaiser, Christoph ^{[15
]}

Eeckhout, Eric ^{[16
]}

Escaned, Javier ^{[17
]}

Garcia-Garcia, Hector ^{[18
]}

Waksman, Ron ^{[18
]}

机构：

[1] Lukaskrankenhaus Neuss, Neuss, Germany

[2] Univ Rostock, Vivantes Klinikum Friedrichshain & Urban, Berlin, Germany

[3] Univ Rostock, Dept Cardiol, Berlin, Germany

[4] Vivantes, Berlin, Germany

[5] Inst Dante Pazzanese Cardiol, Sao Paulo, SP, Brazil

[6] Segeberger Kliniken, Herzzentrum, Bad Segeberg, Germany

[7] Univ Sao Paulo, Fac Med, InCor, Sao Paulo, SP, Brazil

[8] Erasmus MC, Thoraxctr, Rotterdam, Netherlands

[9] Cardiovasc Ctr ZNA Middelheim, Antwerp, Belgium

[10] Thoraxcentrum Twente, Enschede, Netherlands

[11] Aarhus Univ Hosp, Aarhus, Denmark

[12] Aalst OLV Hosp, Cardiovasc Res Ctr, Aalst, Belgium

[13] Univ Heart Ctr Freiburg Bad Krozingen, Cardiol, Bad Krozingen, Germany

[14] Helios Amper Klinikum, Dachau, Germany

[15] Univ Hosp Basel, Basel, Switzerland

[16] Lausanne Univ Hosp, CH-1011 Lausanne, Switzerland

[17] Hosp Clin San Carlos, IdISSC, Madrid, Spain

[18] MedStar Washington Hosp Ctr, Washington, DC USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期

关键词：

D O I：

10.1016/j.jacc.2018.08.1152

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-63

引用

页码：B27 / B28

页数：2

共 40 条

[1] Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries at 36-Month Follow-Up: BIOSOLVE-II and BIOSOLVE-III
Haude, Michael
Ince, Hueseyin
Kische, Stephan
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro A.
Van Mieghem, Nicolas
Verheye, Stefan
von Birgelen, Clemens
Christiansen, Evald
Neumann, Franz-Josef
Witzenbichler, Bernhard
Kaiser, Christoph
Eeckhout, Eric
Escaned, Javier
Garcia-Garcia, Hector
Waksman, Ron
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B187 - B187
[2] Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude, Michael
Ince, Hueseyin
Kische, Stephan
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro Alves
Van Mieghem, Nicolas M.
Verheye, Stefan
von Birgelen, Clemens
Christiansen, Evald Hoj
Barbato, Emanuele
Garcia-Garcia, Hector M.
Waksman, Ron
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (07) : E502 - E511
[3] Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 12-month follow-up-BIOSOLVE-II and BIOSOLVE-III
Haude, Michael
Ince, Hueseyin
Kische, Stephan
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro A.
Van Mieghem, Nicolas
Verheye, Stefan
von Birgelen, Clemens
Christiansen, Evald
Valgimigli, Marco
Wijns, William
Neumann, Franz-Josef
Witzenbichler, Bernhard
Escaned, Javier
Garcia-Garcia, Hector
Waksman, Ron
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B6 - B7
[4] Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up-BIOSOLVE-II
Haude, Michael
Ince, Hueseyin
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro A.
von Birgelen, Clemens
Christiansen, Evald
Wijns, William
Neumann, Franz-Josef
Eeckhout, Eric
Escaned, Javier
Waksman, Ron
Garcia-Garcia, Hector
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B118 - B118
[5] Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude, Michael
Ince, Huseyin
Kische, Stephan
Abizaid, Alexandre
Tolg, Ralph
Lemos, Pedro Alves
Van Mieghem, Nicolas M.
Verheye, Stefan
von Birgelen, Clemens
Christiansen, Evald Hoj
Wijns, William
Garcia-Garcia, Hector M.
Waksman, Ron
EUROINTERVENTION, 2017, 13 (04) : 432 - 439
[6] Long-term Clinical Data and Multimodality Imaging Analysis of the BIOSOLVE-II Study with the Drug-eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries - BIOSOLVE-II
Haude, Michael
Ince, Hueseyin
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro A.
von Birgelen, Clemens
Christiansen, Evald
Barbato, Emanuele
Neumann, Franz-Josef
Kaiser, Christoph
Eeckhout, Eric
Escaned, Javier
Garcia-Garcia, Hector
Waksman, Ron
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B143 - B144
[7] Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II
Haude, Michael
Ince, Huseyin
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro
von Birgelen, Clemens
Christiansen, Evald Hoj
Wijns, William
Neumann, Franz-Josef
Kaiser, Christoph
Eeckhout, Eric
Lim, Soo Teik
Escaned, Javier
Garcia-Garcia, Hector
Waksman, Ron
CIRCULATION, 2016, 134
[8] Safety, Clinical Performance and multi-modality imaging data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 12-month followup-BIOSOLVE-II
Haude, Michael
Ince, Hueseyin
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro
von Birgelen, Clemens
Christiansen, Evald
Wijns, William
Neumann, Franz-Josef
Kaiser, Christoph
Eeckhout, Eric
Lim, Soo Teik
Escaned, Javier
Garcia-Garcia, Hector Manel
Waksman, Ron
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B12 - B13
[9] Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude, Michael
Ince, Huseyin
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro Alves
von Birgelen, Clemens
Christiansen, Evald Hoj
Wijns, William
Neumann, Franz-Josef
Kaiser, Christoph
Eeckhout, Eric
Lim, Soo Teik
Escaned, Javier
Onuma, Yoshinobu
Garcia-Garcia, Hector M.
Waksman, Ron
EUROPEAN HEART JOURNAL, 2016, 37 (35) : 2701 - 2709
[10] Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
Haude, Michael
Ince, Hueseyin
Abizaid, Alexandre
Toelg, Ralph
Lemos, Pedro Alves
von Birgelen, Clemens
Christiansen, Evald Hoj
Wijns, William
Neumann, Franz-Josef
Kaiser, Christoph
Eeckhout, Eric
Teik Lim, Soo
Escaned, Javier
Garcia-Garcia, Hector M.
Waksman, Ron
LANCET, 2016, 387 (10013): : 31 - 39

← 1 2 3 4 →